CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
By David Moher, Sally Hopewell, K. F. Schulz, Victor M. Montori, P. Gøtzsche, P. Devereaux, Diana Elbourne, Matthias Egger, Douglas G. Altman. British medical journal, 2010
6,841 citations recorded by the source corpus.
Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias. A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. It was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs. During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement. After an expert meeting in January 2007, the CONSORT statement has been further revised and is published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias. This explanatory and elaboration document-intended to enhance the use, understanding, and dissemination of the CONSORT statement-has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams are included. The CONSORT 2010 Statement, this revised explanatory and elaboration document, and the associated website (www.consort-statement.org) should be helpful resources to improve reporting of randomised trials.
Subfields: Economics and Econometrics, Public Health, Environmental and Occupational Health, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/3573d4931991b500fbda504de4e471323b8c85ef
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Douglas G. Altman
- David Moher
- K. F. Schulz
- Gunther Eysenbach
- Stuart J. Pocock
- John P. A. Ioannidis
- Diana Elbourne
- P. Gøtzsche
In Public Health, Environmental and Occupational Health
- Douglas G. Altman
- David Moher
- K. F. Schulz
- John P. A. Ioannidis
- Stuart J. Pocock
- P. Gøtzsche
- Gunther Eysenbach
- W. Lin
In Statistics and Probability
- Douglas G. Altman
- David Moher
- K. F. Schulz
- John P. A. Ioannidis
- Gunther Eysenbach
- Julian P. T. Higgins
- P. Gøtzsche
- Stuart J. Pocock
Citations in the corpus
- Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. (2013, methodology): “Thus, in order to allow adjudication of the methods used by the authors, the approach taken should be clearly described and the potential effect on the validity of the PRO findings should be discussed when relevant.(2,22,23) Item 13a.”
- Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. (2006, methodology): “The updated CONSORT 2010 Statement comprises a 25-item checklist and a participant flow diagram.(4) In the 2010 update, some new items and subitems were introduced, wording was simplified and clarified, and the specificity of some items was made more explicit by breaking them into subitems.”
- What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. (2014, methodology): “Diagram of the study selection process according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.(12,43) CINAHL, Cumulative Index to Nursing and Allied Health Literature; PBSC, Psychology and Behavioral Sciences Collection; PROMs, patient-reported outcome measures.”
- Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa (2012, background): “Across the 27 outcomes the number of studies per metaanalysis varied (median (IQR1, IQR3), 6 [5, 8]).”
- IDEAS (Integrate, Design, Assess, and Share): A Framework and Toolkit of Strategies for the Development of More Effective Digital Interventions to Change Health Behavior (2016, methodology): “For further guidance on RCTs, researchers may consult the evidence-based Consolidated Standards of Reporting Trials (CONSORT) 2010 guidelines [83].”
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials (2010, methodology): “* We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration (13) for important clarifications on all the items.”
- Effects of professional development on the quality of teaching: Results from a randomised controlled trial of Quality Teaching Rounds (2017, methodology): “In brief, the project involved a rigorously designed RCT adhering to the Consolidated Standards of Reporting Trials (CONSORT) guidelines for group trials (Moher et al., 2010).”
- Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials (2012, methodology): “Future trials should report the blinding status of these groups, as specified in the CONSORT (Consolidated Standards of Reporting Trials) Statement (35, 36).”